Multicampus Corporation (KOSDAQ:067280)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	201,510	177,211	202,103	209,215	273,817	202,029
Market Cap Growth	-11.11%	-12.32%	-3.40%	-23.59%	35.53%	-1.01%
Enterprise Value	74,001	76,097	135,059	167,091	253,323	200,390
Last Close Price	34000.00	29900.00	31732.73	31266.32	39996.03	29312.51
PE Ratio	6.84	5.70	6.41	6.91	13.44	20.28
Forward PE	-	11.57	11.57	11.57	11.57	11.57
PS Ratio	0.58	0.50	0.56	0.59	0.89	0.78
PB Ratio	0.95	0.80	1.02	1.21	1.96	1.68
P/TBV Ratio	1.15	0.91	1.17	1.40	2.33	2.67
P/FCF Ratio	4.61	3.86	3.46	4.16	6.07	7.39
P/OCF Ratio	4.56	3.81	3.40	4.11	5.94	7.29
EV/Sales Ratio	0.21	0.22	0.38	0.47	0.82	0.77
EV/EBITDA Ratio	1.32	1.29	2.30	2.71	5.42	5.98
EV/EBIT Ratio	2.03	1.96	3.35	4.07	9.57	14.60
EV/FCF Ratio	1.69	1.66	2.31	3.32	5.62	7.33
Debt / Equity Ratio	0.16	0.17	0.23	0.30	0.36	0.22
Debt / EBITDA Ratio	0.62	0.63	0.78	0.84	1.09	0.79
Debt / FCF Ratio	0.79	0.81	0.79	1.03	1.13	0.97
Asset Turnover	1.11	1.12	1.19	1.30	1.37	1.31
Quick Ratio	2.85	3.10	2.58	1.93	1.52	1.42
Current Ratio	3.25	3.39	2.85	2.37	1.87	1.88
Return on Equity (ROE)	14.64%	15.06%	17.28%	19.56%	15.80%	8.56%
Return on Assets (ROA)	7.32%	7.69%	8.34%	9.35%	7.35%	4.32%
Return on Capital (ROIC)	9.36%	9.70%	10.77%	12.36%	9.80%	5.82%
Return on Capital Employed (ROCE)	15.10%	15.40%	16.90%	18.60%	14.30%	9.80%
Earnings Yield	14.62%	17.53%	15.59%	14.46%	7.44%	4.93%
FCF Yield	21.69%	25.92%	28.93%	24.06%	16.47%	13.54%
Dividend Yield	6.19%	7.02%	5.04%	2.56%	1.50%	1.71%
Payout Ratio	32.19%	30.53%	15.05%	11.75%	14.54%	35.48%
Buyback Yield / Dilution	-	-	-	-	-0.53%	-0.10%
Total Shareholder Return	6.19%	7.02%	5.04%	2.56%	0.97%	1.61%

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.